As one of the world’s leading medical institutions, Sheba continuously collaborates with international partners to advance biotechnology, medical innovation, and healthcare in general.
In line with our commitment to providing top-notch patient care, Sheba’s Jusidman Oncology Hospital has become Israel’s leading cancer treatment facility. To further our goal of providing the best possible cancer care, Sheba is honored to conclude a sister institution agreement with MD Anderson Cancer Center, ranked as the best cancer treatment center in the United States for 12 of the past 15 years by US News & World Report.
Sheba and MD Anderson: Sister Institutions
As sister institutions, Sheba and MD Anderson continue to collaborate closely in all aspects of oncological treatment.
“As a former trainee and member of MD Anderson Cancer Center’s faculty, and as a member of Sheba Medical Center’s leadership, I know both systems very well,” explains Prof. Amir Onn, program director of the Sheba-MD Anderson Cancer Center Sister Institution Program. “It became obvious that combining the capabilities and drive to excel of both Centers would greatly benefit our institutions and our patients. Our shared vision is to advance knowledge in cancer research for the benefit of cancer patients in Israel, Texas, and worldwide.”
The Sheba and MD Anderson agreement is aimed at promoting comprehensive cooperation in oncology training, treatment, as well as research, and includes joint programs in physician education and training, clinical services, research collaborations, quality assurance initiatives, faculty exchange visits, scientific endeavors, nursing and other technical support staff training, and more.